XML 36 R25.htm IDEA: XBRL DOCUMENT
v3.26.1

Summary of Significant Accounting and Reporting Policies (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2026
Accounting Policies [Abstract] |
Schedules of Concentration of Risk, by Risk Factor | Accounts receivable from customers representing 10% or more of the Company’s total accounts receivable were as follows:
| March 31, |  | December 31,
| 2026 |  | 2025
Customer A | 24% |  | —
Customer B | 13% |  | 11%
Customer C | 10% |  | —
Customer D | — |  | 14%
Customer E | — |  | 10%
* Customer accounted for less than 10% of total accounts receivable at period end. Revenue from customers representing 10% or more of the Company’s total revenue was as follows:
| Three Months Ended March 31,
| 2026 |  | 2025
Customer B | 10% |  | —
Customer F | — |  | 12%
* Customer accounted for less than 10% of total revenue during the period.
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | The following outstanding securities were excluded from the computation of diluted net loss per share because the effect would be anti-dilutive.
| March 31,
| 2026 |  | 2025
Restricted Stock Unit (“RSU”) Grants | 4,207,079 |  |  | 1,474,294 |
Employee Stock Purchase Plan | 153,099 |  |  | — |
Contingently issuable shares to the CEO | 14,124 |  |  | — |

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 275 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20 + Details
Name: | us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration